Epstein–Barr virus-associated lymphoma: current understanding and treatment strategies
Blood Research · 2026-12 · 61 (1)
DOI: 10.1007/s44313-026-00127-4 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Blood Research, online erschienen am 07.03.2026. Verfasst von Hee Young Ju. Beteiligte Einrichtung: Department of Pediatrics, Samsung Medical Center, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea. hyju320@gmail.com. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Epstein–Barr virus (EBV) infection is well-known for its high prevalence rate, association with several diseases including cancer and autoimmune conditions, and a wide variety of symptoms and prognosis. When acquired at a young age, primary infections are often asymptomatic; however, in adolescence and young adulthood, symptomatic infections develop, such as in infectious mononucleosis. A special feature of EBV infection is its ability to establish a latent infection in B cells which can lead to long-term infection. Subsequent cellular transformation and viral protein expression can result to EBV-mediated carcinogenesis. Latent proteins expressed by EBV play a role in the pathogenesis of EBV infection and carcinogenesis. These proteins are responsible for a diverse range of functions including cell transformation, cell reprogramming, immune evasion, immune suppression, angiogenesis, cell cycle regulation, and B-cell receptor mimicry. EBV infection is associated with diffuse large B-cell lymphoma, Hodgkin lymphoma, NK/T cell lymphoma, Burkitt lymphoma, post-transplant lymphoproliferative disorders, and primary CNS lymphoma. The clinical presentation varies depending on the specific disease and EBV status, with EBV-positive lymphomas generally associated with poorer prognosis than EBV-negative cases. This review aimed to examine the current understanding of the pathogenesis of EBV-associated lymphoma and to evaluate emerging and accepted therapeutic strategies.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Samsung Medical Center, 81 Irwon-Ro, Gangnam-Gu, Seoul, 06351, Korea. hyju320@gmail.com.
Zitieren
APA
Ju, H. Y. (2026). Epstein–Barr virus-associated lymphoma: current understanding and treatment strategies. Blood Research, 61(1). https://doi.org/10.1007/s44313-026-00127-4
Vancouver
Ju HY. Epstein–Barr virus-associated lymphoma: current understanding and treatment strategies. Blood Research. 2026;61(1). doi:10.1007/s44313-026-00127-4
BibTeX
@article{Ju2026,
author = {Ju, Hee Young},
title = {Epstein–Barr virus-associated lymphoma: current understanding and treatment strategies},
journal = {Blood Research},
year = {2026},
volume = {61},
number = {1},
doi = {10.1007/s44313-026-00127-4}
}
EUVIMED